These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19997605)

  • 1. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women.
    Joshi D; Quadri M; Gangane N; Joshi R; Gangane N
    PLoS One; 2009 Dec; 4(12):e8180. PubMed ID: 19997605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epstein Barr virus and invasive mammary carcinomas: EBNA, EBERs and molecular profile in a population of West Algeria].
    Yahia R; Zaoui C; Derbale W; Boudi H; Chebloune Y; Sahraoui T; Elkebir FZ
    Ann Biol Clin (Paris); 2018 Jan; 76(1):75-80. PubMed ID: 29336321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Epstein-Barr Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females.
    Mashaly M; Ghorab D; Hegazy M; Abdelkhalek M; Gaballah K; Elzehery R
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):641-650. PubMed ID: 35225477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Epstein–Barr Virus DNA in Formalin-Fixed Paraffin-Embedded Tissue of Patients with Ductal Breast Carcinoma.
    Sharifpour C; Makvandi M; Samarbafzadeh A; Talaei-Zadeh A; Ranjbari N; Nisi N; Azaran A; Jalilian S; Varnaseri M; Pirmoradi R; Ahmadi Angali K
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):687-692. PubMed ID: 30909665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
    Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
    Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein-Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis.
    Shahi V; Agarwal P; Qayoom S; Kumar V; Tewari S; Raghuvanshi S; Singh US; Goel MM
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3717-3723. PubMed ID: 36444584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.
    Bertrand KA; Birmann BM; Chang ET; Spiegelman D; Aster JC; Zhang SM; Laden F
    Blood; 2010 Nov; 116(18):3547-53. PubMed ID: 20647565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study.
    Kayamba V; Monze M; Asombang AW; Zyambo K; Kelly P
    Pan Afr Med J; 2016; 23():45. PubMed ID: 27217871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
    PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women.
    Kadivar M; Monabati A; Joulaee A; Hosseini N
    Pathol Oncol Res; 2011 Sep; 17(3):489-92. PubMed ID: 21207256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins.
    Mechelli R; Anderson J; Vittori D; Coarelli G; Annibali V; Cannoni S; Aloisi F; Salvetti M; James JA; Ristori G
    Mult Scler; 2011 Nov; 17(11):1290-4. PubMed ID: 21757535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
    J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
    Munger KL; Levin LI; O'Reilly EJ; Falk KI; Ascherio A
    Mult Scler; 2011 Oct; 17(10):1185-93. PubMed ID: 21685232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advancement on relationship between Epstein-Barr virus and breast cancer].
    He JR; Song EW; Ren ZF
    Ai Zheng; 2009 Aug; 28(8):827-30. PubMed ID: 19664328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.